15th Annual Diagnostic Coverage and Reimbursement Conference: East

December 2019 | Boston, MA
Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

Within the rapidly evolving healthcare market, in-vitro diagnostic test developers and laboratories face unique challenges in obtaining product coverage and reimbursement as payer and health authority perspectives continue to focus on cost-efficiency and patient outcomes as primary objectives. Manufacturers must substantiate product value in direct correlation to health outcomes more than ever before, providing robust evidence of not only scientific effectiveness but also optimized cost-savings.

Core Topics to be Addressed:

  • Payer Perspectives on Diagnostic Evidence & Access
  • Maximizing Coverage through Laboratory Benefit Management
  • Evidence Targets: Generating & Leveraging Clinical Evidence
  • Defining Diagnostic Value Relative to Costs for Payer Networks
  • Impact of Increasing Demand for Prior Authorizations
  • Evolving Health Policy Impact on Test Coverage & Reimbursement

Program Highlights:

  • Robust Industry Participation & Support
  • Interactive Small-Group Discussions Throughout
  • Stakeholder Perspectives Including:
    • Payer Medical Directors
    • Payer Contracting Executives
    • Laboratory Benefit Managers

Audience

75 Attendees

All attendees come directly from laboratories and diagnostic companies

Distinguished Presenters

Speaker recruitment in process

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This